Yamazaki, M.; Kawano, H.; Miyoshi, M.; Kimura, T.; Takahashi, K.; Muto, S.; Horie, S.
Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy. Int. J. Mol. Sci. 2024, 25, 2088.
https://doi.org/10.3390/ijms25042088
AMA Style
Yamazaki M, Kawano H, Miyoshi M, Kimura T, Takahashi K, Muto S, Horie S.
Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy. International Journal of Molecular Sciences. 2024; 25(4):2088.
https://doi.org/10.3390/ijms25042088
Chicago/Turabian Style
Yamazaki, Mai, Haruna Kawano, Miho Miyoshi, Tomoki Kimura, Keiji Takahashi, Satoru Muto, and Shigeo Horie.
2024. "Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy" International Journal of Molecular Sciences 25, no. 4: 2088.
https://doi.org/10.3390/ijms25042088
APA Style
Yamazaki, M., Kawano, H., Miyoshi, M., Kimura, T., Takahashi, K., Muto, S., & Horie, S.
(2024). Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy. International Journal of Molecular Sciences, 25(4), 2088.
https://doi.org/10.3390/ijms25042088
